COPD Archive

Lonhala Magnair Now Available for Long-Term COPD Maintenance

Lonhala Magnair Now Available for Long-Term COPD Maintenance

Lonhala Magnair is available as a 25mcg strength inhalation solution per 1mL vial.

Simple Lung Function Tests in Primary Care Help ID Early COPD

Simple Lung Function Tests in Primary Care Help ID Early COPD

Peak flow meter, microspirometry are optimal, with full spirometry for positive results.

Sleep Quality in COPD May Predict Overall Quality of Life

Sleep Quality in COPD May Predict Overall Quality of Life

Sleep quality in patients with chronic obstructive pulmonary disease may be a significant predictor of multiple metrics of quality of life.

Two Inhalers Go Head-to-Head in COPD Exacerbation Study

Two Inhalers Go Head-to-Head in COPD Exacerbation Study

Study authors concluded, "Combining tiotropium and olodaterol did not reduce exacerbation rate as much as expected compared with tiotropium alone."

COPD: Disease Management Care vs Recommended Care Alone

COPD: Disease Management Care vs Recommended Care Alone

Disease management added to recommended care in chronic obstructive pulmonary disease was not superior to recommended care alone.

Efficacy of Different Doses of Glycopyrronium Via a Metered Dose Inhaler in COPD

Efficacy of Different Doses of Glycopyrronium Via a Metered Dose Inhaler in COPD

Four different doses of glycopyrronium delivered via metered dose inhaler were compared for safety and efficacy in the treatment of chronic obstructive pulmonary disease.

Prevent Treatment Nonadherence in Asthma, COPD: Build Strong Patient Relationships

Prevent Treatment Nonadherence in Asthma, COPD: Build Strong Patient Relationships

Patients with asthma or chronic obstructive pulmonary disease have especially high rates of nonadherence, even in comparison with other chronic diseases.

Specific COPD Questionnaire Cutoff Threshold May Identify More Symptomatic Patients

Specific COPD Questionnaire Cutoff Threshold May Identify More Symptomatic Patients

The Clinical COPD Questionnaire cutoff point of 1.4 demonstrated a better agreement with other COPD measures in patients with more symptomatic disease.

Emphysema Threshold on CT Imaging May Have Predictive Value for COPD

Emphysema Threshold on CT Imaging May Have Predictive Value for COPD

Patients with chronic obstructive pulmonary disease with 5% emphysema based on thoracic computed tomography (CT) imaging may be at a greater risk for poor outcomes.

COPD Combination Therapy May Improve Lung Hyperinflation

COPD Combination Therapy May Improve Lung Hyperinflation

Combination treatment with indacaterol-glycopyrronium may improve cardiac function in patients with chronic obstructive pulmonary disease.

COPD Mortality Risk and Physical Activity Have Dose-Response Relationship

COPD Mortality Risk and Physical Activity Have Dose-Response Relationship

Individuals with chronic obstructive pulmonary disease who met physical activity guidelines experienced the greatest reductions in all-cause, CVD, and respiratory mortality risk.

Glucocorticoids Do Not Increase Fracture Risk in COPD

Glucocorticoids Do Not Increase Fracture Risk in COPD

Intermittent use of high-dose glucocorticoids did not increase the risk for fracture in patients with COPD.

Lung Cancer Risk May Be Predicted by Frequency of COPD Exacerbations

Lung Cancer Risk May Be Predicted by Frequency of COPD Exacerbations

Independent predictive factors of lung cancer in chronic obstructive pulmonary disease may include frequency of exacerbations, in addition to airflow obstruction and visual emphysema.

COPD, Respiratory Symptoms Associated With "Western" Diet

COPD, Respiratory Symptoms Associated With "Western" Diet

Researchers used data from the Atherosclerosis Risk in Communities Study to assess associations between dietary pattern and pulmonary assessments.

Severe COPD Exacerbations, Hospitalizations Reduced With Azithromycin

Severe COPD Exacerbations, Hospitalizations Reduced With Azithromycin

Long-term continuous cyclic azithromycin therapy for severe chronic obstructive pulmonary disease was associated with reductions in exacerbations and hospitalizations.

COPD Prevalence, Hospitalizations, and Deaths in Rural Areas

COPD Prevalence, Hospitalizations, and Deaths in Rural Areas

Rural areas have a significantly higher prevalence of chronic obstructive pulmonary disease.

Extrafine Inhaled Triple Therapy vs Dual Bronchodilator Therapy for COPD

Extrafine Inhaled Triple Therapy vs Dual Bronchodilator Therapy for COPD

The TRIBUTE study was the first long-term trial that specifically compared the effects of the extrafine inhaled corticosteroid-containing triple therapy regimen of beclomethasone dipropionate, formoterol fumarate, and glycopyrronium with the dual bronchodilator combination of indacaterol plus glycopyrronium for COPD.

Concomitant Use of Beta-Blockers, Beta-Agonists in COPD With CV Risk

Concomitant Use of Beta-Blockers, Beta-Agonists in COPD With CV Risk

Patients with COPD and heightened cardiovascular risk received respiratory benefits from long-acting beta-agonist therapy without increasing their cardiovascular risk, regardless of beta-blocker therapy.

Predictors of Mortality After Hospitalization for COPD Exacerbation

Predictors of Mortality After Hospitalization for COPD Exacerbation

One-year mortality after the initial hospitalization for chronic obstructive pulmonary disease exacerbation was related to clinical characteristics of the patient and of the index event.

Long-Term Inhaled Corticosteroid Use in COPD May Increase Fracture Risk

Long-Term Inhaled Corticosteroid Use in COPD May Increase Fracture Risk

Patients with chronic obstructive pulmonary disease had a modest increased risk for hip and upper extremity fractures when taking long-term, high-dose inhaled corticosteroids.

COPD-Related Lung Transplantation: How Can We Improve Survival Rates?

COPD-Related Lung Transplantation: How Can We Improve Survival Rates?

Lung transplantation can improve survival in patients with chronic obstructive pulmonary disease, but several variables can affect the surgery's success.

Palliative Care for COPD: Physicians' Views and Treatment Patterns

Palliative Care for COPD: Physicians' Views and Treatment Patterns

Researchers conducted an anonymous survey of medical trainees with a case vignette to determine attitudes regarding palliative care for chronic obstructive pulmonary disease.

Antibiotics for Acute Exacerbations in COPD: Comparison of Effectiveness and Tolerability

Antibiotics for Acute Exacerbations in COPD: Comparison of Effectiveness and Tolerability

Researchers compared the clinical cure and adverse effect rates of multiple antibiotics in the treatment of acute exacerbations in chronic obstructive pulmonary disease.

Blood Biomarkers Add Value to COPD Mortality Predictive Model

Blood Biomarkers Add Value to COPD Mortality Predictive Model

High levels of C-reactive protein and neutrophils as well as low eosinophil count predicted a poor prognosis in COPD.

Respiratory Symptoms in Young Adults: Prognostic Value for Later Lung Function?

Respiratory Symptoms in Young Adults: Prognostic Value for Later Lung Function?

Respiratory symptoms that develop between the ages of 18 and 30 may hold prognostic value for later decline in lung function.

Guiding COPD Management Using Airway Branch Variation

Guiding COPD Management Using Airway Branch Variation

Researchers examined variation in airway branches to determine whether they have an effect on the course of chronic obstructive pulmonary disease.

COPD Exercise Capacity With Long-Acting Bronchodilators

COPD Exercise Capacity With Long-Acting Bronchodilators

Patients with COPD experienced a weighted mean increase in exercise endurance time following treatment with long-acting bronchodilators.

COPD Study Supports Concomitant Beta-Blocker Use in Moderate to Severe Disease

COPD Study Supports Concomitant Beta-Blocker Use in Moderate to Severe Disease

Lung function may not differ between individuals who take beta-blockers vs those who do not for moderate to severe chronic obstructive pulmonary disease.

Clinical Challenge: Elderly Man Presents With Dyspnea at Rest and Chronic Cough

Clinical Challenge: Elderly Man Presents With Dyspnea at Rest and Chronic Cough

An 80-year-old man with a history of smoking, hypertension, diabetes, and COPD presents to the emergency department with dyspnea at rest and chest tightness.

Predicting COPD Exacerbations, Treatment Responses via Eosinophil Counts

Predicting COPD Exacerbations, Treatment Responses via Eosinophil Counts

COPD exacerbation risk and treatment response may be predicted using blood eosinophil counts.

Procalcitonin-Guided Pneumonia Treatment Associated With Improved Outcomes

Procalcitonin-Guided Pneumonia Treatment Associated With Improved Outcomes

Procalcitonin may decrease mortality rates in patients with acute respiratory infections, including pneumonia.

COPD Mortality Predictions by GOLD 2017 vs Previous Versions

COPD Mortality Predictions by GOLD 2017 vs Previous Versions

Although the 2017 GOLD classification did not better predict mortality in patients with chronic obstructive pulmonary disease overall, it did so when patients were extensively categorized by severity.

COPD Continues to Present Screening Challenges, Research Barriers

COPD Continues to Present Screening Challenges, Research Barriers

No data have demonstrated improved mortality, morbidity, or quality of life as a result of screening for COPD in asymptomatic individuals.

Postoperative Pulmonary Complications With Asthma or COPD

Postoperative Pulmonary Complications With Asthma or COPD

Researchers found various risk factors for postoperative pulmonary complications in patients with either asthma or COPD.

Preventing COPD Exacerbations in Upper Respiratory Tract Infections

Preventing COPD Exacerbations in Upper Respiratory Tract Infections

A significant reduction in severe COPD exacerbations was seen with intensified combination therapy at the onset of upper respiratory tract infections.

COPD Home-Based Coaching Intervention: Effects on Physical Activity, Healthcare Utilization

COPD Home-Based Coaching Intervention: Effects on Physical Activity, Healthcare Utilization

Patients with COPD may increase their physical activity levels using a home-based coaching intervention.

Stable Hypercapnic COPD May Benefit From At-Home High-Flow Nasal Cannula Oxygen Therapy

Stable Hypercapnic COPD May Benefit From At-Home High-Flow Nasal Cannula Oxygen Therapy

Patients with stable hypercapnic COPD reported improved health-related quality of life after 6 weeks of at-home high-flow nasal cannula oxygen therapy.

Inhaled Long-Acting Bronchodilators for COPD: Potential Cardiovascular Risk

Inhaled Long-Acting Bronchodilators for COPD: Potential Cardiovascular Risk

Within the first 30 days of therapy, patients with COPD who began using long-acting bronchodilators had a 1.5-fold increased risk for cardiovascular events.

COPD and Asthma Risk in Women With Rheumatoid Arthritis

COPD and Asthma Risk in Women With Rheumatoid Arthritis

Women with rheumatoid arthritis had an increased risk for chronic obstructive pulmonary disease, but did not have an increased risk for asthma compared with women without RA.

Effect of Beta-Blockers on Hospitalization in COPD and Concurrent Heart Failure

Effect of Beta-Blockers on Hospitalization in COPD and Concurrent Heart Failure

Carvedilol may increase the risk for hospitalization in patients with concurrent heart failure and COPD compared with metoprolol/bisoprolol/nebivolol.

A Middle-Aged Man With Worsening COPD

A Middle-Aged Man With Worsening COPD

A middle-aged man diagnosed with COPD presents with shortness of breath at rest with no improvement with nebulizer treatments.

Progression of Emphysema With Regular Aspirin Use

Progression of Emphysema With Regular Aspirin Use

Regular use of aspirin may slow the progression of emphysema.

Nasal High-Flow Oxygen Corrects Hypoxemia, Reduces Hypercapnia in COPD

Nasal High-Flow Oxygen Corrects Hypoxemia, Reduces Hypercapnia in COPD

Nasal high-flow oxygen therapy may be a safe and effective therapy for patients with normocapnic and hypercapnic COPD.

Chronic Lung Disease Research in the Pipeline: An Interview With Augustine M.K. Choi, MD

Chronic Lung Disease Research in the Pipeline: An Interview With Augustine M.K. Choi, MD

Pulmonology Advisor sits down with Augustine M.K. Choi, MD, Stephen and Suzanne Weiss Dean of Weill Cornell Medicine to discuss the latest topics in pulmonary medicine.

Examining the Efficacy of Carbon Monoxide Therapy in Idiopathic Pulmonary Fibrosis: An Interview With Augustine M.K. Choi, MD

Examining the Efficacy of Carbon Monoxide Therapy in Idiopathic Pulmonary Fibrosis: An Interview With Augustine M.K. Choi, MD

Pulmonology Advisor sits down with Augustine M.K. Choi, MD, Stephen and Suzanne Weiss Dean of Weill Cornell Medicine to discuss the latest topics in pulmonary medicine.

Identifying New Therapeutics for Pulmonary Diseases: An Interview With Augustine M.K. Choi, MD

Identifying New Therapeutics for Pulmonary Diseases: An Interview With Augustine M.K. Choi, MD

Pulmonology Advisor sits down with Augustine M.K. Choi, MD of Stephen and Suzanne Weiss Dean of Weill Cornell Medicine to discuss the latest topics in pulmonary medicine.

Overview of Autophagy Research in COPD: An Interview With Augustine M.K. Choi, MD

Overview of Autophagy Research in COPD: An Interview With Augustine M.K. Choi, MD

Pulmonology Advisor sits down with Augustine M.K. Choi, MD, Stephen and Suzanne Weiss Dean of Weill Cornell Medicine to discuss the latest topics in pulmonary medicine.

FDA Approves First Nebulized Long-Acting Muscarinic Antagonist for COPD

FDA Approves First Nebulized Long-Acting Muscarinic Antagonist for COPD

Adults treated with Lonhala Magnair showed statistically significant and clinically important changes in FEV1 at week 12 vs placebo.

Walking in Polluted Area Blunts Cardiorespiratory Benefits

Walking in Polluted Area Blunts Cardiorespiratory Benefits

Concentrations of black carbon, nitrogen dioxide, and particulate matter were higher in traffic-polluted areas, and linked to more instances of cough, sputum, and shortness of breath.

Predicting COPD Exacerbations Using Sputum vs Blood Eosinophils

Predicting COPD Exacerbations Using Sputum vs Blood Eosinophils

Sputum eosinophil counts may be a better predictor of COPD exacerbations compared with serum blood eosinophil counts.

COPD Adverse Outcomes May Increase With Loop Diuretic Use

COPD Adverse Outcomes May Increase With Loop Diuretic Use

Older patients with COPD who use loop diuretics may be at an increased risk for respiratory-related morbidity and mortality.

Noninvasive Ventilation for Acute Hypercapnic Respiratory Failure Related to COPD

Noninvasive Ventilation for Acute Hypercapnic Respiratory Failure Related to COPD

Noninvasive ventilation may reduce mortality in patients with acute hypercapnic respiratory failure related to COPD.

COPD Hospitalization Outcomes Affected by Obesity

COPD Hospitalization Outcomes Affected by Obesity

Patients with obesity who are hospitalized for an acute exacerbation of COPD may have longer hospital stays and more often require mechanical ventilation.

Long-Term Inhaled Corticosteroid Use Associated With Increased Sputum Bacterial Load in COPD

Long-Term Inhaled Corticosteroid Use Associated With Increased Sputum Bacterial Load in COPD

Salmeterol plus fluticasone was associated with a significant increase in sputum bacterial load in chronic obstructive pulmonary disease, compared to salmeterol alone.

COPD Hospitalization Risk With Rheumatoid Arthritis

COPD Hospitalization Risk With Rheumatoid Arthritis

Rheumatoid arthritis increased the risk of COPD-related hospitalization by 47%.

Impulse Oscillometry vs Spirometry for Measuring COPD Airway Obstruction

Impulse Oscillometry vs Spirometry for Measuring COPD Airway Obstruction

Impulse oscillometry is a better monitor of airway obstruction compared with spirometry in patients with chronic obstructive pulmonary disease.

Beta Blockers Linked to Longer Life Expectancy in COPD

Beta Blockers Linked to Longer Life Expectancy in COPD

In a retrospective analysis, researchers examined the efficacy of beta blocker therapy in prolonging patients' lives.

COPD Hospital Readmission, Mortality Risk Predicted by 3-Variable Score

COPD Hospital Readmission, Mortality Risk Predicted by 3-Variable Score

A 3-variable score that encompasses dyspnea score, prednisone use, and prior hospitalization for COPD exacerbations can predict mortality and readmission risk.

Nebulized Glycopyrrolate Improves Lung Function in Severe COPD With CV Risk Factors

Nebulized Glycopyrrolate Improves Lung Function in Severe COPD With CV Risk Factors

A recent study examined whether nebulized glycopyrrolate is safe to use in patients with severe COPD and comorbid cardiovascular risk factors.

Restrictive Spirometry Pattern Associated With Increased Arterial Stiffness

Restrictive Spirometry Pattern Associated With Increased Arterial Stiffness

Both reduced forced vital capacity and a restrictive spirometry pattern was associated with arterial stiffness in both men and women.

Chronic Respiratory Disease Mortality Rates Increase From 1980 to 2014

Chronic Respiratory Disease Mortality Rates Increase From 1980 to 2014

Mortality rates and changes in mortality rates for chronic respiratory diseases in the United States varied by county, sex, and particular disease type.

Inhaled Corticosteroids Do Not Increase Risk for Pneumonia in COPD

Inhaled Corticosteroids Do Not Increase Risk for Pneumonia in COPD

In contrast to previous study findings, inhaled corticosteroids do not appear to increase risk for pneumonia in patients with COPD with moderate airflow limitation.

Using Coronary Artery Calcium to Predict Cardiovascular Events in COPD

Using Coronary Artery Calcium to Predict Cardiovascular Events in COPD

Coronary artery calcium may be the best noninvasive risk marker for predicting cardiovascular events in patients with chronic obstructive pulmonary disease.

Updated Guidelines for Noninvasive Ventilation in Acute Respiratory Failure

Updated Guidelines for Noninvasive Ventilation in Acute Respiratory Failure

The European Respiratory Society and American Thoracic Society have released updated guidelines on the use of noninvasive ventilation for acute respiratory failure.

LABA Plus LAMA Therapy Associated With Fewer Exacerbations in COPD

LABA Plus LAMA Therapy Associated With Fewer Exacerbations in COPD

Long-acting muscarinic antagonists plus long-acting beta-agonists for COPD is associated with fewer exacerbations compared with long-acting beta-agonists plus inhaled corticosteroids.

Targeting Blood Eosinophil Counts in COPD Treatment

Targeting Blood Eosinophil Counts in COPD Treatment

Patients with COPD who have elevated blood eosinophilic levels may benefit from treatment with mepolizumab.

Airway Mucin May Serve as Confirmatory Biomarker for Chronic Bronchitis

Airway Mucin May Serve as Confirmatory Biomarker for Chronic Bronchitis

Current and former smokers with COPD had much higher total airway mucin concentrations compared with patients who had never smoked.

Palliative Care Approaches for Patients with Chronic Obstructive Pulmonary Disease

Palliative Care Approaches for Patients with Chronic Obstructive Pulmonary Disease

A multidisciplinary palliative care team may significantly benefit patients with chronic obstructive pulmonary disease.

Treating Early-Stage Chronic Obstructive Pulmonary Disease With Tiotropium

Treating Early-Stage Chronic Obstructive Pulmonary Disease With Tiotropium

In patients with mild or moderate chronic obstructive pulmonary disease, tiotropium improved the decline in FEV1, as well as quality of life.

Potential Role for Statins in COPD Treatment Armamentarium

Potential Role for Statins in COPD Treatment Armamentarium

Patients with COPD and comorbid cardiovascular disease may benefit from statin treatment depending on their C - reactive protein levels.

Is Undiagnosed COPD Common in Patients Living at High Altitudes?

Is Undiagnosed COPD Common in Patients Living at High Altitudes?

After accounting for individual risk factors, living altitude is not associated with variability in COPD prevalence.

Treating Eosinophilic COPD With Mepolizumab

Treating Eosinophilic COPD With Mepolizumab

Two phase 3 clinical trials examined mepolizumab 100 or 300 mg vs placebo to treat moderate-to-severe COPD exacerbations.

New Biomarker May Enable Selective Antibiotic Use for COPD Exacerbation

New Biomarker May Enable Selective Antibiotic Use for COPD Exacerbation

Researchers hypothosized that increased sputum Gammaproteobacteria:Firmicutes ratio may serve as a biomarker to guide antibiotic treatment in COPD.

Reduced Mortality Risk in COPD Linked to Statin Tx

Reduced Mortality Risk in COPD Linked to Statin Tx

People with COPD have been found to benefit from statin therapies, with reduced risk of all-cause and pulmonary-related mortality.

COPD Exacerbations May Be Reduced With Mucolytic Agents

COPD Exacerbations May Be Reduced With Mucolytic Agents

Patients with COPD treated with mucolytic agents for at least 1 year were better protected against exacerbations compared with patients treated with placebo.

COPD Diagnosis by Physician vs Spirometry: A Validation Study

COPD Diagnosis by Physician vs Spirometry: A Validation Study

Questions involving physician-diagnosed COPD have a low sensitivity and a high specificity.

Efficacy of Tiotropium in Mild to Moderate COPD Examined

Efficacy of Tiotropium in Mild to Moderate COPD Examined

FEV1 was higher in patients who received tiotropium therapy vs those in the placebo group.

COPD Linked to Diabetes and Post-Diabetes Pneumonia

COPD Linked to Diabetes and Post-Diabetes Pneumonia

Patients with chronic obstructive pulmonary disease, particularly with exacerbations, have an increased risk for diabetes development.

Asthma and COPD: Updates on Prevalence, Disability, and Mortality

Asthma and COPD: Updates on Prevalence, Disability, and Mortality

A 2015 update from the 1990 Global Burden of Disease study reveals current prevalence and mortality of asthma and chronic obstructive pulmonary disease.

Improving Lung Function, QoL in COP With Once-Daily Triple-Tx

Improving Lung Function, QoL in COP With Once-Daily Triple-Tx

Study results showed the benefit of single-inhaler triple therapy vs ICS/LABA therapy in COPD.

Does Procalcitonin Testing in COPD Impact Antibiotic Rx?

Does Procalcitonin Testing in COPD Impact Antibiotic Rx?

Researchers found a weak negative association between PCT testing rate and risk-adjusted antibiotic initiation rate.

Pulmonary Rehabilitation Benefits in COPD, Lung Cancer, and Other Respiratory Conditions

Pulmonary Rehabilitation Benefits in COPD, Lung Cancer, and Other Respiratory Conditions

Recent research suggests that perioperative and postoperative pulmonary rehabilitation improves outcomes in patients undergoing thoracic surgery.

Fracture Risk in COPD Increases With Extended Duration of Corticosteroid Use

Fracture Risk in COPD Increases With Extended Duration of Corticosteroid Use

Inhaled corticosteroids for COPD does not increase the risk for fractures when used for short-term periods.

Respiratory Therapist Autonomy With Noninvasive Ventilation May Improve COPD Outcomes

Respiratory Therapist Autonomy With Noninvasive Ventilation May Improve COPD Outcomes

Timely selection and early intervention, attention to comfort, and frequent checks improved outcomes in patients with chronic obstructive pulmonary disease who were treated with noninvasive ventilation.

Errors in Spirometry, Primary Care Contribute to COPD Misdiagnosis

Errors in Spirometry, Primary Care Contribute to COPD Misdiagnosis

Chronic obstructive pulmonary disease may be misdiagnosed in patients as a result of errors related to spirometry tests, errors made in primary care, and differential diagnoses, among others.

Loss of Lung Function Slowed With Fluticasone Furoate Tx

Loss of Lung Function Slowed With Fluticasone Furoate Tx

The rate of forced expiratory volume in one second decline in patients with moderate COPD can be reduced by regular use of fluticasone furoate, either alone or in combination with vilanterol.

Avoiding Pneumonia in Patients With COPD

Avoiding Pneumonia in Patients With COPD

Pneumonia primarily affects young children, smokers, adults 65 years and older, and people with COPD.

Boosting Rehabilitation in Adults With COPD Through Social Support

Boosting Rehabilitation in Adults With COPD Through Social Support

Researchers examined structural social support indicators, including living status, having a partner, number of close friends and relatives, and the presence of a family caregiver.

LABA/LAMA Combination Therapy Associated With Lower CV, Cerebrovascular Risks in COPD

LABA/LAMA Combination Therapy Associated With Lower CV, Cerebrovascular Risks in COPD

Cardio- and cerebrovascular events were more common in patients being treated with combination long-acting β2-agonist (LABA)/long-acting muscarinic antagonist (LAMA) therapies vs LABA/inhaled corticosteroids.

Diagnostic Measures of Lung Function Decline in COPD

Diagnostic Measures of Lung Function Decline in COPD

Comparative measures of inspiratory vs expiratory volumes show a penumbra of lung tissue at higher risk of damage from existing COPD.

Managing COPD Exacerbations With Doxycycline Plus Prednisone

Managing COPD Exacerbations With Doxycycline Plus Prednisone

The first study of antibiotic use in outpatients with COPD exacerbations found that doxycycline plus prednisone did not prolong the time between exacerbations.

Greater Benefit With Azithromycin in COPD Patients With H pylori

Greater Benefit With Azithromycin in COPD Patients With H pylori

Azithromycin therapy is more effective at preventing COPD exacerbations among patients with Helicobacter pylori infection than among those who are H pylori seronegative.

Once-Daily Triple Therapy Effective in Patients With COPD

Once-Daily Triple Therapy Effective in Patients With COPD

In a real-world study, once-daily, single-inhaler triple therapy reduced COPD exacerbations more than twice-daily double therapy.

Page 1 of 2

Sign Up for Free e-newsletters